$OXBR
Oxbridge Re Holdings Ltd

2014 Q1 Form 10-Q Financial Statement

#000119312514196980 Filed on May 13, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $648.0K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $210.0K $0.00
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.000K $0.00
YoY Change
% of Gross Profit
Operating Expenses $255.0K
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $390.0K $0.00
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $393.0K
YoY Change
Net Earnings / Revenue 60.65%
Basic Earnings Per Share $0.28
Diluted Earnings Per Share $0.28
COMMON SHARES
Basic Shares Outstanding 1.387M shares
Diluted Shares Outstanding 1.387M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $28.48M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $49.00K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.870M
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $37.53M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $240.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $240.0K
Total Long-Term Liabilities $0.00
Total Liabilities $3.055M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $978.0K
YoY Change
Common Stock $6.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.48M
YoY Change
Total Liabilities & Shareholders Equity $37.53M
YoY Change

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $393.0K
YoY Change
Depreciation, Depletion And Amortization $1.000K $0.00
YoY Change
Cash From Operating Activities -$50.00K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $50.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.250M
YoY Change
Cash From Investing Activities $1.200M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.000K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.63M
YoY Change
NET CHANGE
Cash From Operating Activities -50.00K
Cash From Investing Activities 1.200M
Cash From Financing Activities 26.63M
Net Change In Cash 27.78M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$50.00K
Capital Expenditures $50.00K
Free Cash Flow -$100.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6.00
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6000000 shares
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6000000 shares
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8230700 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6000000 shares
CY2014Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1.00 pure
CY2014Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8230700 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
7.50
CY2014Q1 us-gaap Reinsurance Payable
ReinsurancePayable
1953000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33491000
CY2014Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2014Q1 us-gaap Net Capital
NetCapital
6800000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
34475000
CY2014Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
242000
CY2014Q1 us-gaap Unearned Premiums
UnearnedPremiums
860000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
978000
CY2014Q1 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
0
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
6000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37530000
CY2014Q1 us-gaap Liabilities
Liabilities
3055000
CY2014Q1 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
CY2014Q1 us-gaap Minimum Net Capital Required For Entity1
MinimumNetCapitalRequiredForEntity1
500
CY2014Q1 us-gaap Investments
Investments
0
CY2014Q1 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
41000
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8865000
CY2014Q1 us-gaap Reinsurance Receivables Paid Losses Recoverable
ReinsuranceReceivablesPaidLossesRecoverable
0
CY2014Q1 us-gaap Assets
Assets
37530000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28483000
CY2014Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
37348000
CY2014Q1 us-gaap Deferred Policy Acquisition Costs Net
DeferredPolicyAcquisitionCostsNet
33000
CY2014Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
59000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49000
CY2014Q1 oxbru Uncertain Tax Position
UncertainTaxPosition
0
CY2014Q1 oxbru Loss Experience Refund Payable
LossExperienceRefundPayable
2300000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1115350 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1115350 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Reinsurance Payable
ReinsurancePayable
1367000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6595000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
7449000
CY2013Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
511000
CY2013Q4 us-gaap Unearned Premiums
UnearnedPremiums
2036000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
853000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11363000
CY2013Q4 us-gaap Liabilities
Liabilities
3914000
CY2013Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10118000
CY2013Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
417000
CY2013Q4 us-gaap Assets
Assets
11363000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
695000
CY2013Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
10813000
CY2013Q4 us-gaap Deferred Policy Acquisition Costs Net
DeferredPolicyAcquisitionCostsNet
69000
CY2013Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
64000
CY2014Q1 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
7.50
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4884650 shares
CY2014Q1 oxbru Closing Price Per Share Common Stock
ClosingPricePerShareCommonStock
9.38
CY2014Q1 oxbru Number Of Warrant Unit Sold
NumberOfWarrantUnitSold
1 shares
CY2014Q1 oxbru Number Of Trading Days
NumberOfTradingDays
P10D
CY2014Q1 oxbru Number Of Ordinary Shares Offered For Sale
NumberOfOrdinarySharesOfferedForSale
1 shares
CY2013Q2 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
7.50
CY2013Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1115350 shares
CY2013Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6700000
CY2013Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3479892
CY2014Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
us-gaap Increase Decrease In Loss And Loss Adjustment Expense Reserve
IncreaseDecreaseInLossAndLossAdjustmentExpenseReserve
0
CY2013 us-gaap Payments For Brokerage Fees
PaymentsForBrokerageFees
116651
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
CY2013Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
CY2013Q1 us-gaap Revenues
Revenues
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
CY2013Q1 us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
CY2013Q1 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
CY2013Q1 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2013Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
CY2013Q1 us-gaap Interest Paid
InterestPaid
CY2013Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
CY2013Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
CY2013Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2013Q1 us-gaap Depreciation
Depreciation
CY2013Q1 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
CY2013Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
CY2013Q1 oxbru Decrease Increase In Offering Costs
DecreaseIncreaseInOfferingCosts
CY2013Q1 oxbru Proceeds From Contributed Warrant
ProceedsFromContributedWarrant
CY2014Q1 dei Trading Symbol
TradingSymbol
OXBRU
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
OXBRIDGE RE HOLDINGS Ltd
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001584831
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2014Q1 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.48 pure
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1386719 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2014Q1 us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<p><font size="2"><strong><u>Allowance for uncollectible receivables:</u></strong> Management evaluates credit quality by evaluating the exposure to individual counterparties; where warranted management also considers the credit rating or financial position, operating results and/or payment history of the counterparty. Management establishes an allowance for amounts for which collection is considered doubtful. Adjustments to previous assessments are recognized as income in the year in which they are determined. At March&#xA0;31, 2014, no receivables were determined to be overdue or impaired and, accordingly, no allowance for uncollectible receivables has been established.</font></p>
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1205000
CY2014Q1 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0169 pure
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1386719 shares
CY2014Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-1253000
CY2014Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.24
CY2014Q1 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
For income tax positions meeting the more likely than not threshold, the tax amount recognized in the financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority.
CY2014Q1 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.08 pure
CY2014Q1 us-gaap Revenues
Revenues
648000
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5000
CY2014Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
268000
CY2014Q1 us-gaap Increase Decrease In Loss And Loss Adjustment Expense Reserve
IncreaseDecreaseInLossAndLossAdjustmentExpenseReserve
0
CY2014Q1 us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
41000
CY2014Q1 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
58000
CY2014Q1 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-586000
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5080000
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2014Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-36000
CY2014Q1 us-gaap Interest Paid
InterestPaid
0
CY2014Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
648000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
393000
CY2014Q1 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
347000
CY2014Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21821000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50000
CY2014Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2014Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5000000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
212000
CY2014Q1 us-gaap Dividends Common Stock
DividendsCommonStock
268000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
26633000
CY2014Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-1176000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27788000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-50000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-269000
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000
CY2014Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
29300000
CY2014Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2014Q1 us-gaap Depreciation
Depreciation
1000
CY2014Q1 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0
CY2014Q1 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
43000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
255000
CY2014Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
21816000
CY2014Q1 oxbru Dividends Declared
DividendsDeclared
267684
CY2014Q1 oxbru Amortization Of Broker Placement Fees
AmortizationOfBrokerPlacementFees
29162
CY2014Q1 oxbru Decrease Increase In Offering Costs
DecreaseIncreaseInOfferingCosts
-417000
CY2014Q1 oxbru Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
0 shares
CY2014Q1 oxbru Net Proceeds After Deducting Underwriters Commission
NetProceedsAfterDeductingUnderwritersCommission
26900000
CY2014Q1 oxbru Proceeds From Contributed Warrant
ProceedsFromContributedWarrant
5080000
CY2014Q1 oxbru Collateral Released By Insurer
CollateralReleasedByInsurer
1660000

Files In Submission

Name View Source Status
0001193125-14-196980-index-headers.html Edgar Link pending
0001193125-14-196980-index.html Edgar Link pending
0001193125-14-196980.txt Edgar Link pending
0001193125-14-196980-xbrl.zip Edgar Link pending
d711304d10q.htm Edgar Link pending
d711304dex311.htm Edgar Link pending
d711304dex312.htm Edgar Link pending
d711304dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
oxbru-20140331.xml Edgar Link completed
oxbru-20140331.xsd Edgar Link pending
oxbru-20140331_cal.xml Edgar Link unprocessable
oxbru-20140331_def.xml Edgar Link unprocessable
oxbru-20140331_lab.xml Edgar Link unprocessable
oxbru-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending